LeMaitre Vascular, Inc. (LMAT) Earnings Call Analysis
NASDAQ · Healthcare · Medical Instruments & Supplies
Next earnings call: 2026-08-04
(Q2 2026)
— full calendar
Earnings Reports
-
Lumate Vascular (LMAT) Q1 2026: Gross Margin Expands 350bps as Autograph Drives Premium Mix
May 06, 2026
-
LeMaitre Vascular (LMAT) Q4 2025: Price Increases Drive 9% Organic Growth as International Expansion Accelerates
February 26, 2026
-
LeMaitre Vascular (LMAT) Q3 2025: 300bps Margin Expansion Signals Pricing Power and Biologics Upside
November 07, 2025
-
LeMaitre Vascular (LMAT) Q2 2025: 15% Organic Growth Anchored by 8% Price, Guidance Raised on International Momentum
August 06, 2025
-
LeMaitre Vascular (LMAT) Q1 2025: Sales Force Expands 27 Reps, Lifting Organic Growth to 13%
July 03, 2025